Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yjmcc.2017.12.014PMID 29291394PMCID PMC5856457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study.

  2015cited by this paper
• Gene network and canonical pathway analysis in canine myxomatous mitral valve 1 disease : A microarray study 2 3

  2015influential reference
• Quantification and simulation of layer-specific mitral valve interstitial cells deformation under physiological loading.

  2015cited by this paper
• Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease

  2015cited by this paper
• 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• Impact of ethnicity on cardiac adaptation to exercise

  2014cited by this paper
• 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• Architectural Trends in the Human Normal and Bicuspid Aortic Valve Leaflet and Its Relevance to Valve Disease

  2014cited by this paper
• Molecular biology of calcific aortic valve disease: towards new pharmacological therapies

  2014cited by this paper
• Serotonin Enhances Megakaryopoiesis and Proplatelet Formation via p‐Erk1/2 and F‐Actin Reorganization

  2014cited by this paper
• Osteopontin–CD44v6 Interaction Mediates Calcium Deposition via Phospho-Akt in Valve Interstitial Cells From Patients With Noncalcified Aortic Valve Sclerosis

  2014cited by this paper
• Circulating Soluble Receptor for Advanced Glycation End Product Identifies Patients With Bicuspid Aortic Valve and Associated Aortopathies

  2014cited by this paper
• 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• Passing Messages between Biological Networks to Refine Predicted Interactions

  2013cited by this paper
• Antioxidant Enzymes Reduce DNA Damage and Early Activation of Valvular Interstitial Cells in Aortic Valve Sclerosis

  2013cited by this paper
• Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

  2013cited by this paper
• Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm.

  2013cited by this paper
• Modulation of Transforming Growth Factor-&bgr; Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers

  2012cited by this paper
• Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease.

  2012cited by this paper
• Mitral valve prolapse.

  2012cited by this paper
• Human myxomatous mitral valve prolapse: Role of bone morphogenetic protein 4 in valvular interstitial cell activation

  2012cited by this paper
• Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

  2011cited by this paper
• Cellular Mechanisms in Mitral Valve Disease

  2011cited by this paper
• Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

  2011cited by this paper
• Heart valve structure and function in development and disease.

  2011cited by this paper
• Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls

  2011cited by this paper
• Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease.

  2010cited by this paper
• Drug-induced fibrotic valvular heart disease.

  2009cited by this paper
• Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.

  2009cited by this paper
• Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.

  2009influential reference
• Serum serotonin concentrations in dogs with degenerative mitral valve disease.

  2009cited by this paper
• Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

  2009cited by this paper
• Serotonin receptors.

  2008influential reference
• 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.

  2008cited by this paper
• Long-term serotonin effects in the rat are prevented by terguride.

  2007cited by this paper
• Differences in Tissue-Remodeling Potential of Aortic and Pulmonary Heart Valve Interstitial Cells

  2007cited by this paper
• Carcinoid heart disease.

  2007cited by this paper
• Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis.

  2006cited by this paper
• Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease.

  2006cited by this paper
• In-vivo dynamic deformation of the mitral valve anterior leaflet.

  2006cited by this paper
• 5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats

  2005cited by this paper
• Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor

  2005cited by this paper
• Long-Term Serotonin Administration Induces Heart Valve Disease in Rats

  2005cited by this paper
• Serotonin transporter mechanisms and cardiac disease.

  2005cited by this paper
• Deficiency of the 5-Hydroxytryptamine Transporter Gene Leads to Cardiac Fibrosis and Valvulopathy in Mice

  2005cited by this paper
• Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

  2002cited by this paper
• Anorexogen-Related Cardiac Valvulopathy

  2002cited by this paper
• Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study.

  2002cited by this paper
• Molecular, pharmacological and functional diversity of 5-HT receptors.

  2002influential reference
• Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

  2002cited by this paper
• Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

  2000cited by this paper
• Mitral valve prolapse

  1985cited by this paper
• Carcinoid Heart Disease

  1974cited by this paper

• Serotonin transporter downregulation is associated with aortic stenosis, and early profibrotic remodeling is mitigated by pharmacological inhibition of HTR2B receptor.

  2026cites this paper
• Specific serotonin receptor antagonist reduces murine calcific atherosclerosis.

  2026cites this paper
• Whole exome sequencing of 80 cases of sporadic mitral valve prolapse reveals novel disease-associated genes and variants in a Southern Chinese population

  2025influential citation
• Unraveling the Molecular Complexity of Myxomatous Mitral Valve Degeneration: Integrating Transcriptomic and miRNA Profiling Using Random Forests with Boruta Feature Selection

  2025cites this paper
• Cardiology's best friend: Using naturally occurring disease in dogs to understand heart disease in humans

  2025cites this paper
• Simulated Effects of Acute Left Ventricular Myocardial Infarction On Mitral Regurgitation in an Ovine Model.

  2024cites this paper
• Mendelian randomization reveals interactions of the blood proteome and immunome in mitral valve prolapse

  2024cites this paper
• Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium.

  2024cites this paper
• TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease

  2023cites this paper
• Editorial: Heart valve diseases: from molecular mechanisms to clinical implications

  2023cites this paper
• Development of Pharmacophore Models for the Important Off-Target 5-HT2B Receptor.

  2023cites this paper
• Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation

  2023cites this paper
• Clinical manifestation of neuroendocrine tumor – carcinoid heart disease

  2023cites this paper
• Telotristat ethyl reverses myxomatous changes in mice mitral valves

  2022cites this paper
• Bioinformatic analysis of potential biomarkers and mechanisms of immune infiltration in mitral regurgitation complicated by atrial fibrillation

  2022cites this paper
• Connections for Matters of the Heart: Network Medicine in Cardiovascular Diseases

  2022cites this paper
• First quantitative dosages: Strong correlations between non-5-HT2Rs serotonin receptors on normal human heart valves

  2022influential citation
• The Discovery of 5-HT2B Receptor Pharmacology Through the Understanding of Drug-Induced Valvulopathy

  2021cites this paper
• Update in carcinoid heart disease - the heart of the matter

  2021cites this paper
• Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling after Myocardial Infarction.

  2021cites this paper
• Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor

  2021influential citation
• 5-HT2B Receptor in Cardiopulmonary Disease

  2021cites this paper
• Serotonin and Cardiac Valves Degeneration in Dog

  2021cites this paper
• Comparative transcriptomic pro ling of myxomatous mitral valve disease in the Cavalier King

  2020cites this paper
• Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel

  2020cites this paper
• Disease Severity-Associated Gene Expression in Canine Myxomatous Mitral Valve Disease Is Dominated by TGFβ Signaling

  2020cites this paper
• A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse

  2020cites this paper
• Inhibition and down regulation of the serotonin transporter contribute to the progression of degenerative mitral regurgitation

  2020cites this paper
• Aortic Valve Regurgitation: Pathophysiology and Implications for Surgical Intervention in the Era of TAVR

  2020influential citation
• Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

  2020cites this paper
• Network Medicine in the Age of Biomedical Big Data

  2019cites this paper
• Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?

  2019cites this paper
• Survival of activated myofibroblasts in canine myxomatous mitral valve disease and the role of apoptosis.

  2019cites this paper
• Mechanical strain induces a pro-fibrotic phenotype in human mitral valvular interstitial cells through RhoC/ROCK/MRTF-A and Erk1/2 signaling pathways.

  2019cites this paper
• Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration

  2019influential citation
• Drug-associated valvular heart diseases and serotonin-related pathways: a meta-analysis

  2019cites this paper
• The sEROtonergic pathway: a hERO for the brain, a zERO for the valves?

  2019cites this paper